Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Toxicities, dose reduction and delay of docetaxel and paclitaxel chemotherapy in breast cancer without distant metastases

Kim Woo Young, Woo Sang Uk, Seo Jae Hong, Son Gil Soo, Lee Jae Bok, Bae Jeoung Won

Year : 2011| Volume: 7| Issue : 4 | Page no: 412-415

   This article has been cited by
1 Toxicity profile of taxanes in Tunisian cancer patients: A retrospective study of 90 cases
Sonia Ben Nasr, Aref Zribi, Mouna Ben Hassen, Yosr Doghri, Ichrak Ben Abdallah, Emna Trigui, Sana Fendri, Jihen Ayari, Mehdi Balti, Abderrazek Haddaoui
Bulletin du Cancer. 2021; 108(3): 266
[Pubmed]  [Google Scholar] [DOI]
2 Exploring pharmacogenetics of paclitaxel- and docetaxel-induced peripheral neuropathy by evaluating the direct pharmacogenetic-pharmacokinetic and pharmacokinetic-neuropathy relationships
Daniel L Hertz
Expert Opinion on Drug Metabolism & Toxicology. 2021; 17(2): 227
[Pubmed]  [Google Scholar] [DOI]
3 Vitamin D deficiency increases severity of paclitaxel-induced peripheral neuropathy
Theodore S. Jennaro, Fang Fang, Kelley M. Kidwell, Ellen M. Lavoie Smith, Kiran Vangipuram, Monika L. Burness, Jennifer J. Griggs, Catherine Van Poznak, Daniel F. Hayes, N. Lynn Henry, Daniel L. Hertz
Breast Cancer Research and Treatment. 2020; 180(3): 707
[Pubmed]  [Google Scholar] [DOI]
4 Patterns of Anthracycline-Based Chemotherapy-Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in Ethiopia: A Prospective Observational Study
Diriba Alemayehu Gadisa, Mathewos Assefa, Gosaye Mekonen Tefera, Getnet Yimer
Journal of Oncology. 2020; 2020: 1
[Pubmed]  [Google Scholar] [DOI]
5 Toxicity profile of Doxorubicin-Cyclophosphamide and Doxorubicin-Cyclophosphamide followed by Paclitaxel regimen and its associated factors among women with breast cancer in Ethiopia: A prospective cohort study
Diriba Alemayehu Gadisa, Mathewos Assefa, Shu-Hua Wang, Getnet Yimer
Journal of Oncology Pharmacy Practice. 2020; 26(8): 1912
[Pubmed]  [Google Scholar] [DOI]
6 Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study
Ning Sun, Bo Shen, Jiali Zhu, Xiaomei Zhang, Huayun Zhu, Geyu Liang, Deliang Yang, Jianwei Lu, Yan Zhang
Journal of Translational Medicine. 2020; 18(1)
[Pubmed]  [Google Scholar] [DOI]
7 “Chemotherapy-periodized” Exercise to Accommodate for Cyclical Variation in Fatigue
Medicine & Science in Sports & Exercise. 2020; 52(2): 278
[Pubmed]  [Google Scholar] [DOI]
8 Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells
Jiangchuan Sun, Mingyue Yin, Shenyin Zhu, Li Liu, Yi Zhu, Zhigang Wang, Ronald X. Xu, Shufang Chang
Ultrasonics Sonochemistry. 2016; 28: 319
[Pubmed]  [Google Scholar] [DOI]
9 Feasibility of two schedules of weekly paclitaxel in HER2-negative early breast cancer in a Brazilian community setting
Iuri A. Santana,Julia Andrade Oliveira,Julianne Maria da Silva Lima,Laura Testa,José Roberto M. Piato,Paulo M. Hoff,Max S. Mano
Breast Cancer. 2014;
[Pubmed]  [Google Scholar] [DOI]
10 A Phase IV Clinical Trial of Patients with Solid Tumors Receiving Lenograstim as Primary Prophylaxis for Chemotherapy-Induced Neutropenia, in a Docetaxel-Based Regimen
Samuel J. Fourie,Alicia McMaster,Rashem Mothilal,Keith I. Maart
Journal of Cancer Research. 2014; 2014: 1
[Pubmed]  [Google Scholar] [DOI]
11 Non-viral nanocarriers for siRNA delivery in breast cancer
Jing Zhang,Xiang Li,Leaf Huang
Journal of Controlled Release. 2014;
[Pubmed]  [Google Scholar] [DOI]
12 An oncolytic herpes simplex virus vector, G47Δ, synergizes with paclitaxel in the treatment of breast cancer
Zeng, W.-G. and Li, J.-J. and Hu, P. and Lei, L. and Wang, J.-N. and Liu, R.-B.
Oncology Reports. 2013; 29(6): 2355-2361
[Pubmed]  [Google Scholar]
13 Toxicities of taxanes
Ladislav, S.
Journal of Cancer Research and Therapeutics. 2013; 9(1): 161
[Pubmed]  [Google Scholar]
14 Decreased body mass index is associated with poor prognosis in patients with multiple myeloma
Sung-Hoon Jung,Deok-Hwan Yang,Jae-Sook Ahn,Seung-Shin Lee,Seo-Yeon Ahn,Yeo-Kyeoung Kim,Hyeoung–Joon Kim,Je-Jung Lee
Annals of Hematology. 2013;
[Pubmed]  [Google Scholar] [DOI]


Read this article